or
forgot password
  • cancer clinical trials in chapel hill, NC

  • Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Colorectal Cancer
    Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver Metastases
    University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center
    Chapel Hill, North Carolina 27599
    Liver Neoplasms, Colonic Neoplasms, Metastatic Cancer to Liver
    De-intensification of Radiation and Chemotherapy for Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Carcinoma
    University of North Carolina at Chapel Hill, Department of Radiation Oncology
    Chapel Hill, North Carolina 27599
    Carcinoma, Squamous Cell, Head and Neck Neoplasms, Oropharyngeal Neoplasms
    Erlotinib With or Without Bevacizumab in Treating Patients With Stage IV Non-Small Cell Lung Cancer With EGFR Mutations
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Stage IV Non-small Cell Lung Cancer
    Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Combined Type Small Cell Lung Cancer, Fusiform Type Small Cell Lung Cancer, Lymphocyte-like Type Small Cell Lung Cancer, Polygonal Type Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohorts in KRAS Wild Type Metastatic Colorectal and Pancreatic Cancer
    University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center
    Chapel Hill, North Carolina 27599
    Advanced Solid Tumors, Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer
    Stereotactic Radiosurgery or Other Local Ablation Then Erlotinib in Epidermal Growth Factor Receptor (EGFR)
    Lineberger Comprehensive Cancer Center
    Chapel Hill, North Carolina 27599-7305
    Non Small Cell Lung Cancer
    Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    Lenalidomide as Consolidation and Maintenance in Adults >/= 60 Years of Age With AML Following Standard Induction
    University of North Carolina at Chapel Hill - Lineberger Comprehensive Cancer Center
    Chapel Hill, North Carolina 27599
    Acute Myeloid Leukemia
    Induction Chemotherapy w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma
    University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center
    Chapel Hill, North Carolina 27599
    Hodgkin Lymphoma, Adult
    Intensity-Modulated Radiation Therapy, Pemetrexed Disodium, and Erlotinib Hydrochloride in Treating Patients With Recurrent or Second Primary Head and Neck Cancer
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity
    Study of ACY-1215 in Combination With Lenalidomide, and Dexamethasone in Multiple Myeloma
    UNC Lineberger Comprehensive Cancer Center
    Chapel Hill, North Carolina
    Multiple Myeloma
    Erlotinib Hydrochloride and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery
    University of North Carolina Health Care
    Chapel Hill, North Carolina 27599-7600
    Squamous Cell Carcinoma of the Skin, Stage I Squamous Cell Carcinoma of the Hypopharynx, Stage I Squamous Cell Carcinoma of the Larynx, Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage I Squamous Cell Carcinoma of the Oropharynx, Stage I Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage I Verrucous Carcinoma of the Larynx, Stage I Verrucous Carcinoma of the Oral Cavity, Stage II Squamous Cell Carcinoma of the Hypopharynx, Stage II Squamous Cell Carcinoma of the Larynx, Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage II Squamous Cell Carcinoma of the Oropharynx, Stage II Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage II Verrucous Carcinoma of the Oral Cavity
    Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder Cancer
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Bladder Cancer
    Combination Chemotherapy With or Without Rituximab in Treating Younger Patients With Stage III-IV Non-Hodgkin Lymphoma or B-Cell Acute Leukemia
    University of North Carolina
    Chapel Hill, North Carolina 27599
    B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Diffuse Large Cell Lymphoma, L3 Childhood Acute Lymphoblastic Leukemia, Stage III Childhood Large Cell Lymphoma, Stage IV Childhood Large Cell Lymphoma, Untreated Childhood Acute Lymphoblastic Leukemia
    Double Cord Versus Haploidentical (Blood and Marrow Transplant Clinical Trials Network #1101)
    University of North Carolina Hospital at Chapel Hill
    Chapel Hill, North Carolina 27599
    Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma, Follicular Lymphoma, Hodgkin Lymphoma, Mantle Cell Lymphoma
    Effects of HQK-1001 in Patients With Sickle Cell Disease
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Sickle Cell Disease, Sickle Cell Anemia, Sickle Cell Disorders, Hemoglobin S Disease, Sickling Disorder Due to Hemoglobin S
    Phase I Study LJM716 Combined With Trastuzumab in Patients With HER2 Overexpressing Metastatic Breast or Gastric Cancer
    UNC/Lineberg Comprehensive Cancer Center UNC 2
    Chapel Hill, North Carolina 27514
    Advanced HER2-positive Breast Cancer or Gastric Cancer
    Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Childhood Central Nervous System Choriocarcinoma, Childhood Central Nervous System Embryonal Tumor, Childhood Central Nervous System Germ Cell Tumor, Childhood Central Nervous System Germinoma, Childhood Central Nervous System Mixed Germ Cell Tumor, Childhood Central Nervous System Teratoma, Childhood Central Nervous System Yolk Sac Tumor, Childhood Pineal Parenchymal Tumor
    Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI
    University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center
    Chapel Hill, North Carolina 27599
    Advanced Adenocarcinoma of the Colon or Rectum
    Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
    The University Of North Carolina At Chapel Hill
    Chapel Hill, North Carolina 27599-7235
    Head and Neck Cancer, Squamous Cell Carcinoma of the Head and Neck
    Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Recurrent Uterine Sarcoma, Uterine Leiomyosarcoma
    Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum, Signet Ring Adenocarcinoma of the Colon, Signet Ring Adenocarcinoma of the Rectum, Stage IV Colon Cancer, Stage IV Rectal Cancer
    Positron Emission Tomography (PET) Study for Staging of Muscle Invasive Bladder Cancer
    Lineberger Comprehensive Cancer Center
    Chapel Hill, North Carolina 27599-7305
    Bladder Cancer
    Imaging Correlates of Renal Cell Carcinoma Biological Features
    Lineberger Comprehensive Cancer Center
    Chapel Hill, North Carolina 27599-7305
    Renal Cell Carcinoma
    Neratinib in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Breast Neoplasms
    Determining the Sensitivity of Sentinel Lymph Nodes Identified With Robotic Fluorescence Imaging
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Endometrial Cancer, Cervical Cancer
    Metformin for the Treatment of Endometrial Hyperplasia
    The University Of North Carolina At Chapel Hill
    Chapel Hill, North Carolina 27599-7235
    Endometrial Hyperplasia, Endometrial Hyperplasia Without Atypia
    Intravesical Administration of INSTILADRIN (rAd-IFN With Syn3) in Patients With Bladder Cancer
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Superficial Bladder Cancer
    Post Operative Adjuvant Therapy De-intensification Trial for Human Papillomavirus-related, p16+ Oropharynx Cancer
    University of North Carolina School of Medicine
    Chapel Hill, North Carolina 27599
    Oropharyngeal Neoplasms
    Lung Cancer Surgery: Decisions Against Life Saving Care - The Intervention
    The University Of North Carolina At Chapel Hill
    Chapel Hill, North Carolina 27599-7235
    Non-small Cell Lung Cancer
    Finding Predictors of Side Effects to Chemoradiation Treatment in Elderly Patients With Head and Neck Cancer
    UNC Lineberger Comprehensive Cancer Center
    Chapel Hill, North Carolina
    Head and Neck Cancer
    FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer
    Lineberger Comprehensive Cancer Center
    Chapel Hill, North Carolina 27599-7305
    Pancreatic Cancer
    Safety, Efficacy and Pharmacokinetic Study of PRLX 93936 in Patients With Multiple Myeloma
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Multiple Myeloma
    FITShop: Promoting Physical Activity in Black Barbershops
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Physical Activity
    Single Arm on the Tolerability of Weekly Nab-paclitaxel
    UNC Lineberger Comprehensive Cancer Center
    Chapel Hill, North Carolina
    Non Small Cell Lung Cancer (NSCLC)
    Study of MK-3475 Versus Chemotherapy in Participants With Advanced Melanoma (P08719/MK-3475-002 AM1)
    Call for Information (Investigational Site 0029)
    Chapel Hill, North Carolina 27599
    Malignant Melanoma
    Pilot Study to Evaluate Individualized Choice of Antidepressants in Patients With Cancer
    University of North Carolina Hospital
    Chapel Hill, North Carolina 27599
    Major Depressive Disorder, Neoplasms
    LCCC 1128: Open Label Phase II Trial of the BRAF Inhibitor (Dabrafenib) and the MEK Inhibitor (Trametinib) in Unresectable Stage III and Stage IV BRAF Mutant Melanoma; Correlation of Resistance With the Kinome and Functional Mutations
    Lineberger Comprehensive Cancer Center, University of North Carolina
    Chapel Hill, North Carolina 27599
    Stage III Melanoma, Stage IV Melanoma, Unresectable Melanoma, BRAF Mutant Melanoma
    Study Investigating a PEGylated Recombinant Factor VIII (BAX 855) for Hemophilia A (PROLONG-ATE Study)
    University of North Carolina Chapel Hill
    Chapel Hill, North Carolina
    Hemophilia A
    PET/MRI as a Predictor of Response to Pre-op Chemoradiation in Resectable Rectal Cancer: a Pilot Study
    University of North Carolina-Chapel Hill
    Chapel Hill, North Carolina 27599
    Rectal Carcinoma
    Hybrid Pet/MR in the Therapy of Cervical Cancer
    University of North Carolina-Chapel Hill
    Chapel Hill, North Carolina 27599
    Cervix Carcinoma, Cervical Squamous Cell Carcinoma, Cervical Adenosquamous Carcinoma
    Comparison of Stationary Breast Tomosynthesis and 2-D Digital Mammography in Patients With Known Breast Lesions
    The University of North Carolina
    Chapel Hill, North Carolina 27599
    Breast Neoplasms
    Study of Outcomes After Surgery/Treatment to Treat Bladder Cancer
    UNC Lineberger Comprehensive Cancer Center
    Chapel Hill, North Carolina
    Bladder Cancer
    Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
    University of North Carolina Chapel Hill SC
    Chapel Hill, North Carolina 27514
    Chronic Myelogenous Leukemia
    Prevalence of Dysplasia of the Gastric Cardia
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Barrett's Esophagus, Intestinal Metaplasia, Intramucosal Adenocarcinoma
    PET/MRI in CNS and Extra-CNS Tumors of Patients With Neurofibromatosis-1 (NF1)
    University of North Carolina-Chapel Hill
    Chapel Hill, North Carolina 27599
    Neurofibromatosis-1, Optic Glioma, Plexiform Neurofibroma
    Goal Setting for Health Behavior and Psychosocial Issues in Primary Care
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Health Behaviors, Obesity, Substance Abuse, Anxiety, Depression
    Assessment of Ability of Breath Hold for Left-sided Breast Cancer Radiation Therapy to Reduce Side Effects to Heart
    University of North Carolina at Chapel Hill, Department of Radiation Oncology
    Chapel Hill, North Carolina 27599
    Breast Cancer
    Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Colorectal Adenomatous Polyps
    An Extended Use Study of Safety and Efficacy of OncoVEXGM-CSF in Melanoma
    University of North Carolina At Chapel Hill School of Medicine
    Chapel Hill, North Carolina 27599
    Melanoma
    Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
    Site Reference ID/Investigator# 61434
    Chapel Hill, North Carolina 27516
    Hidradenitis Suppurativa
    Young and Strong: An Education and Supportive Care Intervention Study for Young Women With Breast Cancer
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Breast Cancer
    Predicting Tolerance to Radiation Therapy in Older Adults With Cancer
    Radiation Oncology Clinic - UNC Cancer Hospital
    Chapel Hill, North Carolina 27599
    Pre-treatment Loss of Independent Activities of Daily Living
    Primary Prophylaxis of Cerebral Toxoplasmosis in HIV-Infected Patients
    Unc Aids Crs
    Chapel Hill, North Carolina 27599
    Toxoplasmosis, Cerebral, HIV Infections
    A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS
    Unc Aids Crs
    Chapel Hill, North Carolina 27599
    Toxoplasmosis, Cerebral, HIV Infections
    Multi-center Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis
    Univ of North Carolina
    Chapel Hill, North Carolina 275997215
    Meningitis, Cryptococcal, HIV Infections
    An Open Trial of Zidovudine (AZT) Treatment of the AIDS Dementia Complex in Patients With AIDS or Low CD4+ Lymphocyte Counts
    Univ of North Carolina
    Chapel Hill, North Carolina 275997215
    AIDS Dementia Complex, HIV Infections
    Thalidomide for Treatment of Oral and Esophageal Aphthous Ulcers and HIV Viremia in Patients With HIV Infection
    Univ of North Carolina
    Chapel Hill, North Carolina 275997215
    HIV Infections, Stomatitis, Aphthous
    Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV Therapy
    Univ of North Carolina
    Chapel Hill, North Carolina 275997215
    Mycobacterium Avium-intracellulare Infection, HIV Infections